LOGIN  |  REGISTER
Surmodics
Cue Biopharma

InMode to Present at Upcoming Investor Conferences and Events

May 17, 2023 | Last Trade: US$17.64 0.28 1.61

YOKNEAM, Israel, May 17, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at the following investor conferences and events:

BNPP Exane Aesthetics Day

Presenters: Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer
Format: Virtual fireside chat moderated by Navann Ty, Lead Equity Analyst
When: Tuesday, May 23 at 10:00 am ET

A replay of webcast of the presentation can be accessed here.

Barclays West Coast Bus Trip

Presenters: Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer
Format: In-person investor bus tour at InMode's North American headquarters
Location: Irvine, CA
When: Tuesday, May 23 at 10:30 am PT

Jefferies Healthcare Conference

Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside chat moderated by Matt Taylor, Equity Analyst and one-on-one meetings
Location: NYC, NY
When: Wednesday, June 7 at 1:00 pm ET

A live webcast of the presentation can be accessed here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia 
MS-IR LLC 
This email address is being protected from spambots. You need JavaScript enabled to view it. 
917-607-8654 

Astria Therapeutics

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB